Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Gastroenterology. 2021 Jan 6;160(5):1771–1783.e1. doi: 10.1053/j.gastro.2020.12.077

Fig. 2. ZIP4 upregulates YAP1 through miR-373-LATS2 in pancreatic cancer cells.

Fig. 2.

(A). Expression of YAP1 and LATS2 in MIA-V, MIA-ZIP4, AsPC-shV and AsPC-shZIP4 cells. (B). Expression of YAP1 and LATS2 in AsPC-shZIP4 cells with LATS2 knock down. (C). Protein levels of LATS2, YAP1, and ITGA3 in AsPC-shV miR-C, AsPC-shZIP4 miR-C, AsPC-shZIP4 miR-373, MIA-V Anti-C, MIA-ZIP4 Anti-C, and MIA-ZIP4 Anti-miR-373 cells. (D-F). mRNA levels of LATS2, YAP1 and ITGA3 in AsPC-shV miR-C, AsPC-shZIP4 miR-C, AsPC-shZIP4 miR-373, MIA-V Anti-C, MIA-ZIP4 Anti-C, and MIA-ZIP4 Anti-miR-373 cells. * means P< .05, ** means P< .01.